Major Players Keep Remote Patient Monitoring Moving Forward
Medtronic and Roche have made important moves in the remote monitoring market with new partnerships designed to enhance their places in telemedicine, which continues to be an important point of emphasis for providers. Meanwhile, AliveCor, a young company with groundbreaking cardiology technology for the smartphone, has reached an important milestone in Europe.
You may also be interested in...
Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.
Remote monitoring is proving to be the driving force in the industry’s quest to reduce costs by keeping patients out of hospitals, and telemedicine is positioned to become a major part of that scheme. However, telemedicine has a number of components and players, and while the market offers opportunities, it could also prove to be somewhat disruptive to companies and products that do not fit in the envisioned landscape.
Companies developing new digital health technologies say that the US health system needs to upgrade and start adopting tools that can track patients beyond hospital walls. Qualcomm Life aims to assist by merging data into information that health care providers can actually use.